Psychiatry and Neurology, Neurology · Laurel, MS
NPI
1174801765
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1203 Jefferson St
Laurel, MS, 39440
Phone (601) 649-2863
Groups this clinician bills Medicare through
Medicare paid, 2024
$403K
21,913 services
Medicare patients, 2024
967
Average age 75
Drug cost, 2024
$1.3M
13,229 prescriptions
Company payments, 2025
$1,895
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gulshan S Oberoi was code J0585 (injection, onabotulinumtoxina, 1 unit), 15,955 times for 23 patients. In total Gulshan S Oberoi billed 21,913 services in 55 codes, and Medicare paid $403K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 15,955 | 23 | $4.94 | $79K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,168 | 770 | $12.95 | $15K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,149 | 151 | $0.76 | $871 |
| 99214 Office E&M - Established | Office | 942 | 634 | $92.80 | $87K |
| 95886 Electrical Nerve Conductivity | Office | 344 | 181 | $71.42 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 244 | 98 | $62.14 | $15K |
| 99213 Office E&M - Established | Office | 185 | 122 | $67.00 | $12K |
| 99204 Office E&M - New | Office | 166 | 166 | $122.84 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 163 | 70 | $92.91 | $15K |
| 20526 Musculoskeletal | Office | 158 | 103 | $79.39 | $13K |
| 64450 Musculoskeletal | Office | 127 | 85 | $37.89 | $4,812 |
| 95816 Neurologic | Facility | 126 | 118 | $43.77 | $5,515 |
| 95911 Electrical Nerve Conductivity | Office | 105 | 104 | $159.18 | $17K |
| 99205 Office E&M - New | Office | 104 | 104 | $162.73 | $17K |
| 99223 Hospital E&M - Initial | Facility | 96 | 90 | $134.48 | $13K |
By year: 2022 $375K for 18,766 services; 2023 $360K for 20,797 services; 2024 $403K for 21,913 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 61 | 59 | $8.65 | $528 |
| 82607 Clinical Chemistry | 35 | 35 | $14.78 | $517 |
| 80061 Clinical Chemistry | 33 | 30 | $13.12 | $433 |
| 84443 Clinical Chemistry | 32 | 32 | $16.46 | $527 |
Medicare prescription drug claims, 2024
In 2024, the drug Gulshan S Oberoi prescribed most often to Medicare patients was Memantine Hcl, with 1,289 prescriptions and refills. In total Gulshan S Oberoi wrote 13,229 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 1,289 | 2,464 | 371 | $22K |
| Nortriptyline Hcl Generic | 1,061 | 1,845 | 342 | $16K |
| Gabapentin Generic | 1,048 | 1,495 | 261 | $12K |
| Diclofenac Sodium Generic | 722 | 1,140 | 265 | $11K |
| Levetiracetam Generic | 607 | 1,146 | 134 | $17K |
| Meclizine Hcl Generic | 566 | 696 | 220 | $7,423 |
| Rizatriptan Rizatriptan Benzoate | 483 | 503 | 170 | $5,540 |
| Donepezil Hcl Generic | 460 | 1,037 | 136 | $4,039 |
| Ropinirole Hcl Generic | 449 | 863 | 125 | $9,589 |
| Tizanidine Hcl Generic | 409 | 672 | 140 | $4,152 |
| Atorvastatin Calcium Generic | 375 | 873 | 146 | $2,317 |
| Duloxetine Hcl Generic | 359 | 764 | 128 | $6,514 |
| Amitriptyline Hcl Generic | 354 | 776 | 104 | $6,397 |
| Topiramate Generic | 342 | 696 | 109 | $5,122 |
| Primidone Generic | 319 | 541 | 85 | $4,951 |
Brand drugs: - claims; generic drugs: 12,385 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gulshan S Oberoi $1,895 ($1,895 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $327.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.